Suraksha Diagnostic Limited
NSE: SURAKSHA BSE: SURAKSHA
Prev Close
282.25
Open Price
275.1
Volume
23,184
Today Low / High
275.1 / 288
52 WK Low / High
231 / 352.5
Range
268 - 296
Prev Close
281.35
Open Price
265.4
Volume
1,244
Today Low / High
265.4 / 288.35
52 WK Low / High
233.15 / 353.65
Range
268 - 296
The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 282 (target range: 268 - 296), reflecting a change of -0.25 (-0.08857396%). On the BSE, it is listed at 282.3 (target range: 268 - 296), showing a change of 0.95 (0.33766%). The stock price is currently in decline on both exchanges, signaling a downtrend. If you're considering investing in this stock, it's important to monitor the situation closely.
Suraksha Diagnostic Limited Graph
Suraksha Diagnostic Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Suraksha Diagnostic Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 282.00, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 282.30 | 285.12 | 256.61 - 313.64 |
| 287.95 | 230.36 - 345.54 | ||
| 290.77 | 203.54 - 378.00 | ||
| Bearish Scenario | 282.30 | 279.48 | 251.53 - 307.42 |
| 276.65 | 221.32 - 331.98 | ||
| 273.83 | 191.68 - 355.98 |
Overview of Suraksha Diagnostic Limited
ISIN
INE877V01027
Industry
Medical - Diagnostics & Research
Vol.Avg
19,158
Market Cap
14,686,773,756
Last Dividend
0
Official Website
IPO Date
2024-12-06
DCF Diff
185.24
DCF
98
Financial Ratios Every Investor Needs
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 252.09 Cr | 29.52 Cr | 222.57 Cr | 0.8829 | 0.00 Cr | 46.19 Cr | 48.13 Cr | 31.82 Cr | 6.11 | 85.09 Cr | 0.1262 |
| 2024-03-31 | 218.71 Cr | 27.25 Cr | 191.46 Cr | 0.8754 | 0.00 Cr | 34.53 Cr | 40.83 Cr | 23.63 Cr | 4.54 | 72.84 Cr | 0.1080 |
| 2023-03-31 | 190.13 Cr | 27.40 Cr | 76.26 Cr | 0.4011 | 0.00 Cr | 31.27 Cr | 15.59 Cr | 6.52 Cr | 1.25 | 47.48 Cr | 0.0343 |
| 2022-03-31 | 223.19 Cr | 60.41 Cr | 86.29 Cr | 0.3866 | 0.00 Cr | 24.53 Cr | 36.65 Cr | 20.82 Cr | 2.87 | 65.25 Cr | 0.0933 |
| 2021-03-31 | 140.01 Cr | 32.90 Cr | 107.10 Cr | 0.7650 | 0.00 Cr | 38.07 Cr | 67.49 Cr | 6.44 Cr | 1.49 | 23.81 Cr | 0.0460 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 2.25 Cr | 333.52 Cr | 123.29 Cr | 211.2397 Cr | 88.89 Cr | 86.64 Cr | 8.05 Cr | 231.53 Cr | 0.00 Cr | 0.00 Cr | 36.58 Cr | 42.7166 Cr |
| 2024-03-31 | 2.52 Cr | 300.21 Cr | 121.06 Cr | 179.4080 Cr | 90.48 Cr | 87.96 Cr | 6.68 Cr | 216.40 Cr | 0.00 Cr | 0.00 Cr | -48.82 Cr | 39.4140 Cr |
| 2023-03-31 | 2.16 Cr | 281.20 Cr | 125.73 Cr | 155.9260 Cr | 96.87 Cr | 94.71 Cr | 6.16 Cr | 196.40 Cr | 0.00 Cr | 0.00 Cr | 13.16 Cr | 38.3410 Cr |
| 2022-03-31 | 3.19 Cr | 275.96 Cr | 130.13 Cr | 145.8420 Cr | 99.80 Cr | 96.61 Cr | 6.23 Cr | 198.52 Cr | 0.00 Cr | 0.00 Cr | 5.14 Cr | 38.3470 Cr |
| 2021-03-31 | 2.93 Cr | 171.05 Cr | 44.82 Cr | 126.2235 Cr | 16.43 Cr | 13.50 Cr | 4.45 Cr | 116.89 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 24.9561 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 63.3591 Cr | -39.5841 Cr | -24.0482 Cr | 21.3351 Cr | -0.2732 Cr | 2.2468 Cr | -42.0240 Cr | 31.8241 Cr | -2.8114 Cr | 0.0000 Cr | -1.3706 Cr |
| 2024-03-31 | 60.4840 Cr | -34.9960 Cr | -25.1300 Cr | 15.7900 Cr | 0.3580 Cr | 2.5200 Cr | -44.6940 Cr | 31.4530 Cr | -5.3700 Cr | 0.0000 Cr | -0.5160 Cr |
| 2023-03-31 | 44.0960 Cr | -20.7950 Cr | -24.3280 Cr | 30.9290 Cr | -1.0270 Cr | 2.1620 Cr | -13.1670 Cr | 6.7480 Cr | -5.0200 Cr | 0.0000 Cr | 0.0630 Cr |
| 2022-03-31 | 57.8230 Cr | -43.2810 Cr | -14.2850 Cr | 38.5740 Cr | 0.2570 Cr | 3.1890 Cr | -19.2490 Cr | 28.0120 Cr | 2.5960 Cr | 0.0000 Cr | -1.7810 Cr |
| 2021-03-31 | 23.5117 Cr | -27.7083 Cr | 3.2106 Cr | 8.1111 Cr | 2.9321 Cr | 2.9321 Cr | -15.4006 Cr | 6.4351 Cr | 4.8310 Cr | 0.0000 Cr | 1.0012 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | 77.69 Cr | 32.65 Cr | 45.04 Cr | 0.5797 | 12.60 Cr | 7.52 Cr | 1.44 | 23.78 Cr | 0.0968 |
| 2025-09-30 | 78.73 Cr | 32.44 Cr | 46.29 Cr | 0.5880 | 13.97 Cr | 8.99 Cr | 1.73 | 24.97 Cr | 0.1141 |
| 2025-06-30 | 72.59 Cr | 8.75 Cr | 63.84 Cr | 0.8794 | 13.38 Cr | 9.40 Cr | 1.80 | 24.66 Cr | 0.1295 |
| 2025-03-31 | 65.09 Cr | 27.78 Cr | 37.31 Cr | 0.5732 | 11.26 Cr | 7.39 Cr | 1.42 | 20.00 Cr | 0.1135 |
| 2024-12-31 | 59.51 Cr | 6.10 Cr | 33.30 Cr | 0.5595 | 9.43 Cr | 6.15 Cr | 1.18 | 18.86 Cr | 0.1034 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 2.11 Cr | 41.49 Cr | 43.59 Cr | 13.63 Cr | 8.45 Cr | 73.42 Cr | 273.07 Cr | 380.25 Cr | 150.83 Cr |
| 2025-06-30 | 0.00 Cr | 0.00 Cr | 20.11 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -210.23 Cr |
| 2025-03-31 | 2.25 Cr | 17.86 Cr | 22.64 Cr | 13.81 Cr | 8.05 Cr | 47.15 Cr | 231.53 Cr | 333.52 Cr | 123.29 Cr |
| 2024-12-31 | 56.68 Cr | 0.00 Cr | 56.68 Cr | 0.00 Cr | 0.00 Cr | 56.68 Cr | 0.00 Cr | 0.00 Cr | -196.80 Cr |
| 2024-09-30 | 2.03 Cr | 64.72 Cr | 66.75 Cr | 9.02 Cr | 6.85 Cr | 86.61 Cr | 214.28 Cr | 319.56 Cr | 122.76 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 9.40 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2025-03-31 | 7.39 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-12-31 | 6.15 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -2.03 Cr | 0.00 Cr | 2.03 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 13.63 Cr | 18.93 Cr | -15.15 Cr | -6.17 Cr | -2.39 Cr | 2.03 Cr | 4.42 Cr | -12.47 Cr | 6.46 Cr |
| 2024-06-30 | 10.51 Cr | 18.35 Cr | -10.07 Cr | -6.39 Cr | 1.90 Cr | 4.42 Cr | 2.52 Cr | -7.44 Cr | 10.91 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Medical - Diagnostics & Research
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Dr. Lal PathLabs Limited | LALPATHLAB | ₹1,428.70 | ₹238,555,002,304.00 | ₹99,162.00 |
| Sai Life Sciences Ltd. | SAILIFE | ₹925.00 | ₹195,756,612,250.00 | ₹562,918.00 |
| Vijaya Diagnostic Centre Limited | VIJAYA | ₹990.50 | ₹101,749,053,070.00 | ₹65,450.00 |
| Metropolis Healthcare Limited | METROPOLIS | ₹1,880.10 | ₹97,449,155,190.00 | ₹13,605.00 |
Key Executives
Gender: Not Specified
Year Born: 1960
Gender: male
Year Born:
Gender: male
Year Born:
Gender: male
Year Born:
Gender: female
Year Born:
Gender: female
Year Born: 1973
Gender: female
Year Born:
FAQs about Suraksha Diagnostic Limited
The CEO is Ritu Mittal.
The current price is ₹282.00.
The range is ₹231-352.5.
The market capitalization is ₹1,468.68 crores.
The P/E ratio is 44.11.
The company operates in the Healthcare sector.
Overview of Suraksha Diagnostic Limited (ISIN: INE877V01027) is a leading Medical - Diagnostics & Research in India. With a market capitalization of ₹1,468.68 crores and an average daily volume of 19,158 shares, it operates in the Medical - Diagnostics & Research. The company last declared a dividend of ₹0.